Perigon Wealth Management’s Twist Bioscience TWST Stock Holding History

Perigon Wealth Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,553	Closed	-$266K	–	720
2022 Q3	$266K	Sell	7,553 -31	-0.4%	-$1.32K	0.02%	458
2022 Q2	$265K	Buy	7,584 +1,835	+32%	+$65K	0.02%	458
2022 Q1	$284K	Buy	5,749 +560	+11%	+$31K	0.02%	475
2021 Q4	$402K	Buy	5,189 +2,072	+66%	+$213K	0.03%	388
2021 Q3	$333K	Buy	3,117 +166	+6%	+$19K	0.03%	391
2021 Q2	$393K	Buy	2,951 +64	+2%	+$7.44K	0.03%	351
2021 Q1	$358K	Buy	+2,887	New	+$438K	0.04%	352

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Perigon Wealth Management's TWST Position: Q4 2022 in Review

Perigon Wealth Management sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 7,553 shares — an estimated $266K sold.

Perigon Wealth Management first reported a position in TWST in Q1 2021 and held it in 7 quarters. The position peaked at $402K in Q4 2021. 198 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

Perigon Wealth Management reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
Perigon Wealth Management sold 7,553 Twist Bioscience shares in Q4 2022, an estimated $266K.
Perigon Wealth Management first reported a position in Twist Bioscience in Q1 2021 and held it in 7 quarters.
Perigon Wealth Management's Twist Bioscience position peaked at $402K in Q4 2021.
198 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Perigon Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.